Ser351
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser351  -  NR2C2 (mouse)

Site Information
HVISRDQstPIIEVE   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 7990482

In vivo Characterization
Methods used to characterize site in vivo:
[32P] ATP in vitro ( 1 ) , mutation of modification site ( 1 )
Disease tissue studied:
liver cancer ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
AMPKA1 (human) ( 1 )
Kinases, in vitro:
AMPKA1 (human) ( 1 )
Treatments:
acadesine ( 1 ) , metformin ( 1 ) , siRNA ( 1 )

Downstream Regulation
Effects of modification on NR2C2:
intracellular localization ( 1 )
Effects of modification on biological processes:
signaling pathway regulation ( 1 ) , transcription, inhibited ( 1 )

References 

1

Kim E, et al. (2011) Metformin Inhibits Nuclear Receptor TR4-Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity. Diabetes 60, 1493-503
21478464   Curated Info